|
|
|
l |
Home | l | UK Companies | l | Genomics Topics | l | Species with sequenced Genomes | l | Contact |
l |
|
Loading...
| ||||||||||||||
Recent Publications by AstraZeneca: | ![]() | |
| Adopting the CEO model--why physician executives should not be required to practice medicine.
Bacterial resistance continues to develop and pose a significant threat,... | AstraZeneca Pharmaceuticals, Wilmington, Delaware, USA. | Physician Exec. 2008 Jul-Aug;34(4):24-6. |
| Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors.
An imidazole series of cyclin-dependent kinase (CDK) inhibitors has been... | AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. | Bioorg Med Chem Lett. 2008 Sep 10.
DOI Direct Link |
| Examining the acute effects of cediranib (RECENTIN, AZD2171) treatment in tumor models: a dynamic contrast-enhanced MRI study using gadopentate.
Cediranib (RECENTIN, AZD2171) is a highly potent inhibitor of the tyrosine... | Department of Enabling Capabilities and Sciences, AstraZeneca, Mereside, | Magn Reson Imaging. 2008 Sep 22.
DOI Direct Link |
| The application and relevance of ex vivo culture systems for assessment of IBD treatment in murine models of colitis.
The aim of this study was to investigate the relevance of mouse ex vivo... | Department of Integrative Pharmacology at AstraZeneca R&D Molndal, Sweden; | Pharmacol Res. 2008 Sep 2.
DOI Direct Link |
| Rationale for reading fluconazole MICs at 24h rather than 48h when testing Candida spp. by the CLSI M27-A2 standard method.
We investigated if CLSI M27-A2 Candida spp. breakpoints for fluconazole... | University of Texas Medical School at Houston, Houston, TX; AstraZeneca, | Antimicrob Agents Chemother. 2008 Sep 22.
DOI Direct Link |
AstraZeneca Patents: | ![]() |
| US Patent No. | Title |
| Non-Utility Patent | Container device |
| 7384950 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 7384951 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 7384954 | 4-substituted imidazoles |
| 7384955 | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them |